GlassScriptPhysician profile
Mark Hc Bouffard
NPI 1528168622
$17,145.80
in general payments reported to CMS, 2019-2025
53 companies · $2,613 in 2025
The $2,613 reported for 2025 was more than what 89% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,641 · 2020: $2,162 · 2021: $5,025 · 2022: $1,668 · 2023: $1,791 · 2024: $1,245 · 2025: $2,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,639 · Travel and Lodging: $1,001 · Education: $8.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,639.46 |
| Travel and Lodging | $1,001.36 |
| Education | $8.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,706.30 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Globus Medical, INC. | $1,421.91 | 2025 | Senza, Vyrsa V1 |
| Biodelivery Sciences International, INC. | $1,411.86 | 2019-2021 | |
| Abbott Laboratories | $1,293.05 | 2019-2024 | Proclaim, Octrode |
| Abbvie INC. | $1,065.96 | 2021-2025 | Qulipta, Ubrelvy |
| Collegium Pharmaceutical, INC. | $979.78 | 2019-2025 | Belbuca, Xtampza |
| Si-Bone, INC. | $537.99 | 2019-2024 | |
| Curonix LLC | $450.60 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $434.78 | 2019 | |
| Nevro Corp. | $366.52 | 2019-2023 | Senza |
| Medtronic, INC. | $350.99 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Spr Therapeutics, INC | $316.55 | 2021-2025 | Sprint Pns System |
| Painteq LLC | $301.40 | 2022-2024 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $236.12 | 2019-2022 | |
| Lilly USA, LLC | $203.24 | 2019-2020 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bouffard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.